Medical history and lifestyle factors have limited impact on time‐to‐first‐treatment in patients with chronic lymphocytic leukemia

Author:

Glimelius Ingrid12ORCID,Kleinstern Geffen34,Robinson Dennis P.4,Mansouri Larry5,Rostgaard Klaus67,Hjalgrim Henrik678,Niemann Carsten Utoft7,Mattsson Mattias1,Rabe Kari G.4,Hampel Paul J.8ORCID,Parikh Sameer A.9,Rosenquist Richard510ORCID,Cerhan James R.4,Slager Susan L.49,Smedby Karin E.2

Affiliation:

1. Department of Immunology, Genetics & Pathology, Cancer Precision Medicine Uppsala University Uppsala Sweden

2. Department of Medicine Solna Division of Clinical Epidemiology Karolinska Institutet Stockholm Sweden

3. School of Public Health University of Haifa Haifa Israel

4. Department of Quantitative Health Sciences Mayo Clinic Rochester Minnesota USA

5. Department of Molecular Medicine and Surgery Karolinska Institutet Stockholm Sweden

6. Epidemiology Research Statens Serum Institut Copenhagen Denmark

7. Danish Cancer Society Research Center Danish Cancer Society Copenhagen Denmark

8. Department of Hematology, Rigshospitalet Copenhagen Denmark

9. Division of Hematology Mayo Clinic Rochester Minnesota USA

10. Clinical Genetics Karolinska University Hospital Stockholm Sweden

Abstract

AbstractBackgroundChronic lymphocytic leukemia (CLL) is a heterogeneous disease. Whereas some patients have an indolent disease, others experience an aggressive course and early death. Our aim was to investigate if modifiable and non‐modifiable medical history and lifestyle factors prior to diagnosis had an impact on the natural course of the disease.MethodIn 1154 CLL patients, we assessed if the weight, physical activity, smoking, and alcohol consumption or non‐modifiable characteristics including family history of lymphoid malignancy and medical history were associated with time‐to‐first‐treatment (TTFT) and adjusted all results for the CLL‐International Prognostic Index (CLL‐IPI).ResultsTTFT was shorter for patients with high/very high‐risk CLL‐IPI than those with low/intermediate risk CLL‐IPI. In the adjusted analysis we did not find additional impact on TTFT besides CLL‐IPI from any environmental characteristics assessed.ConclusionsWe found limited impact of environmental factors on the natural course of CLL (measured as the TTFT in treatment naïve patients) providing valuable knowledge, and potential relief, to share with patients at the time of diagnosis.

Funder

Vetenskapsrådet

Foundation for the National Institutes of Health

Cancerfonden

Radiumhemmets Forskningsfonder

Knut och Alice Wallenbergs Stiftelse

Stockholm läns landsting

Publisher

Wiley

Reference18 articles.

1. What information do cancer patients want and how well are their needs being met?;Chua GP;Ecancermedicalscience,2018

2. Autoimmune and chronic inflammatory disorders and risk of non‐Hodgkin lymphoma by subtype;Smedby KE;J Natl Cancer Inst,2006

3. Design and validity of a clinic‐based case‐control study on the molecular epidemiology of lymphoma;Cerhan JR;Int J Mol Epidemiol Genet,2011

4. Medical history, lifestyle, family history, and occupational risk factors for chronic lymphocytic leukemia/small lymphocytic lymphoma: the InterLymph Non‐Hodgkin Lymphoma Subtypes Project;Slager SL;J Natl Cancer Inst Monogr,2014

5. Infectious mononucleosis, childhood social environment, and risk of Hodgkin lymphoma;Hjalgrim H;Cancer research,2007

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3